Silent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
| Autor: | Zhaosheng Jin, Tong J Gan, E Wang, Lizhe Guo |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Pneumonia Viral Hypoxemia chemistry.chemical_compound Internal medicine Prevalence Humans Medicine Oximetry Hypoxia Lung Review Articles Oxygen saturation (medicine) Hypoxis medicine.diagnostic_test Respiratory distress SARS-CoV-2 business.industry Intensive Care COVID-19 Thrombosis Oxygen–haemoglobin dissociation curve General Medicine medicine.disease Pathophysiology respiratory tract diseases Oxygen Pneumonia Pulse oximetry chemistry Asymptomatic Diseases Microvessels Carboxyhemoglobin Cardiology medicine.symptom business |
| Zdroj: | Medical Science Monitor : International Medical Journal of Experimental and Clinical Research |
| ISSN: | 1643-3750 |
| DOI: | 10.12659/msm.930776 |
| Popis: | During the coronavirus disease 2019 (COVID-19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, patients presented with COVID-19 pneumonia of varying severity. The phenomenon of severe hypoxemia without signs of respiratory distress is also known as silent or hidden hypoxemia. Although silent hypoxemia is not unique to pneumonia due to SARS-CoV-2 infection, this phenomenon is now recognized to be associated with severe COVID-19 pneumonia. Proper management of critically ill patients is the key to reducing mortality. Herein, we summarize the possible and rare factors contributing to silent hypoxemia in patients with COVID-19. Microvascular thrombosis causes dead space ventilation in the lungs, and the flow of pulmonary capillaries is reduced, which leads to an imbalance in the V/Q ratio. The dissociation curve of oxyhemoglobin shifts to the left and limits the release of oxygen to the tissue. SARS-CoV-2 interferes with the synthesis of hemoglobin and reduces the ability to carry oxygen. The accumulation of endogenous carbon monoxide and carboxyhemoglobin will reduce the total oxygen carrying capacity and interfere with pulse oxygen saturation readings. There are also some non-specific factors that cause the difference between pulse oximetry and oxygen partial pressure. We propose some potentially more effective clinical alternatives and recommendations for optimizing the clinical management processes of patients with COVID-19. This review aims to describe the prevalence of silent hypoxemia in COVID-19 pneumonia, to provide an update on what is known of the pathophysiology, and to highlight the importance of diagnosing silent hypoxemia in patients with COVID-19 pneumonia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|